Related Experiment Videos

Indications for cholecystectomy in ligation of the hepatic artery

Surgery, Gynecology & Obstetrics
|April 1, 1981
PubMed

Insights

Hepatic artery ligation for cancer treatment does not necessitate gallbladder removal. Autopsy showed minimal gallbladder changes, insufficient to justify cholecystectomy in these hepatic artery ligation cases.

Area of Science:

  • Hepatobiliary surgery
  • Surgical oncology
  • Gastroenterology

Background:

  • Hepatic artery ligation (HAL) is a recognized treatment for massive bleeding from hepatic trauma and metastatic neoplastic disease.
  • The necessity of concurrent cholecystectomy during HAL is not well-established.
  • Cholecystectomy is often performed with HAL for bleeding control, but its role in neoplastic disease management is less defined.

Purpose of the Study:

  • To evaluate the pathological changes in the gallbladder after hepatic artery ligation (HAL) when performed for neoplastic disease.
  • To determine if gallbladder removal is necessary when HAL is used for treating liver cancer metastases.

Main Methods:

  • Hepatic artery ligation was performed in patients with neoplastic disease, with the gallbladder intentionally left in situ.
  • Gallbladders were examined post-mortem (autopsy).
  • Histopathological analysis was conducted on gallbladder tissues.

Main Results:

  • Autopsy revealed no significant pathological processes within the gallbladder.
  • Microscopic examination showed minor changes: mucosal fibrosis, mild chronic inflammation, and nonspecific mononuclear infiltration.
  • These observed changes were deemed insufficient to indicate pathology.

Conclusions:

  • The pathological changes observed in the gallbladder after HAL for neoplastic disease are minimal.
  • Routine cholecystectomy is not warranted in conjunction with HAL for treating neoplastic disease.
  • Preserving the gallbladder in such cases appears safe and avoids unnecessary surgical intervention.

Related Concept Videos